SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,106.65 107.25
( 0.13%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

58,738.13 1,303.36
(2.27%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Titan Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524717

INE150C01029

36.69382

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

51.26

1805.62

EPS(TTM)

Face Value()

Div & Yield %

6.82

0.11

Back

DLF consolidated net profit rises 10.28% in the September 2026 quarter

Oct 16,2026

Net profit of DLF rose 10.28% to Rs 1301.35 crore in the quarter ended September 2026 as against Rs 1180.09 crore during the previous quarter ended September 2025. Sales declined 23.28% to Rs 1260.58 crore in the quarter ended September 2026 as against Rs 1643.04 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1260.58	1643.04	-23
OPM %	1.83	17.26	-
PBDT	1041.52	839.20	24
PBT	1003.32	809.66	24
NP	1301.35	1180.09	10

81,106.65 107.25 ( 0.13%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

58,738.13 1,303.36 (2.27%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)